MASTL

UniProt ID: Q96GX5
Organism: Homo sapiens
Review Status: COMPLETE
πŸ“ Provide Detailed Feedback

Gene Description

MASTL (Greatwall kinase) is an atypical AGC-family serine/threonine protein kinase whose catalytic domain is interrupted by a long non-conserved insertion. It is activated at mitotic entry by cyclin B-CDK1-dependent phosphorylation and autophosphorylation. Its principal substrates are the small endosulfine proteins ENSA (Ser67) and ARPP19 (Ser62); once phosphorylated, they bind and inhibit the PP2A-B55 phosphatase that otherwise removes CDK1-generated mitotic phosphorylations. By suppressing PP2A-B55, MASTL lets CDK1 substrate phosphorylation accumulate and persist, which is required for a timely G2/M transition, chromosome condensation, maintenance of the spindle assembly checkpoint, and faithful anaphase and cytokinesis; complete loss of MASTL in human cells causes G2 arrest, whereas partial depletion causes premature dephosphorylation of mitotic substrates and mitotic failure. Inactivation of MASTL and reactivation of PP2A-B55 at the end of mitosis are needed for an orderly return to interphase, and the same kinase output supports re-entry into mitosis after recovery from a DNA-damage checkpoint. MASTL is mainly nuclear in interphase, redistributes to the cytoplasm and centrosomes after nuclear envelope breakdown, and moves to the cleavage furrow at mitotic exit. A germline E167D variant is associated with autosomal dominant thrombocytopenia (THC2), and the protein has additional, less well-characterized roles in megakaryocyte and platelet biology.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0000086 G2/M transition of mitotic cell cycle
IMP
PMID:20538976
Loss of human Greatwall results in G2 arrest and multiple mi...
ACCEPT
Summary: MASTL promotes mitotic entry by inhibiting PP2A-B55 through phospho-ENSA/ARPP19; complete siRNA depletion arrests human cells in G2.
Reason: This is the central, best-supported function of the gene. Human RNAi shows G2 arrest on full depletion and mitotic collapse on partial depletion, both rescued by PP2A co-depletion or okadaic acid, and the biochemical mechanism (phosphorylation of ENSA/ARPP19 to make them PP2A-B55 inhibitors) is established in Xenopus and reconstituted with human proteins.
Supporting Evidence:
PMID:20538976
This kinase promotes mitotic entry and maintenance in human cells by inhibiting protein phosphatase 2A (PP2A), a phosphatase that dephosphorylates cyclin B-Cdc2 substrates. The complete depletion of Gwl by siRNA arrests human cells in G2.
PMID:20538976
These phenotypes appear to be mediated by PP2A, as they could be rescued by either a double Gwl/PP2A knockdown or by the inhibition of this phosphatase with okadaic acid.
PMID:21164014
We identified cyclic adenosine monophosphate-regulated phosphoprotein 19 (Arpp19) and Ξ±-Endosulfine as two substrates of Gwl that, when phosphorylated by this kinase, associate with and inhibit PP2A, thus promoting mitotic entry.
GO:0000086 G2/M transition of mitotic cell cycle
IMP
PMID:20818157
MASTL is the human orthologue of Greatwall kinase that facil...
ACCEPT
Summary: MASTL-depleted human cells delay in G2 and condense chromosomes slowly; MASTL sustains cyclin B1-CDK1-dependent mitotic phosphorylation.
Reason: Independent human RNAi study reaching the same conclusion as PMID:20538976; the G2 delay and slow chromosome condensation are direct readouts of a defective G2/M transition.
Supporting Evidence:
PMID:20818157
Cells strongly depleted of MASTL by RNAi delay in G(2) phase and reveal slow chromosome condensation.
PMID:20818157
our experiments indicate that MASTL supports the phosphorylation state of mitotic phospho-proteins downstream of cyclin B1-Cdk1, including the APC/C.
GO:0004672 protein kinase activity
IEA
GO_REF:0000002
ACCEPT
Summary: Generic InterPro-derived protein kinase activity; correct but less specific than the experimentally established serine/threonine (serine) kinase activity.
Reason: The mapping is correct and is a parent of the experimentally supported GO:0004674. An IEA at this level of specificity is acceptable.
Supporting Evidence:
PMID:38123684
This inhibition results in the full activation of mitotic kinases, including MASTL, which phosphorylates ARPP19 on Ser62 (pS62-ARPP19).
PMID:21164013
We report that inhibition of PP2A-B55Ξ΄ results from a small protein, known as Ξ±-endosulfine (Ensa), that is phosphorylated in mitosis by the protein kinase Greatwall (Gwl). This converts Ensa into a potent and specific inhibitor of PP2A-B55Ξ΄.
GO:0004674 protein serine/threonine kinase activity
IBA
GO_REF:0000033
ACCEPT
Summary: PAINT propagation of serine/threonine kinase activity from the deep AGC-kinase node (PTN000683254); MASTL's own IDA is among the descendant evidence.
Reason: The phylogenetic placement at the AGC family node is sound, MASTL is inside that clade, and the activity is directly demonstrated for MASTL on ENSA Ser67 and ARPP19 Ser62. The target appearing in its own WITH/FROM is expected and marks experimental grounding on the target itself.
Supporting Evidence:
PMID:38123684
This inhibition results in the full activation of mitotic kinases, including MASTL, which phosphorylates ARPP19 on Ser62 (pS62-ARPP19).
PMID:21164013
We report that inhibition of PP2A-B55Ξ΄ results from a small protein, known as Ξ±-endosulfine (Ensa), that is phosphorylated in mitosis by the protein kinase Greatwall (Gwl). This converts Ensa into a potent and specific inhibitor of PP2A-B55Ξ΄.
GO:0004674 protein serine/threonine kinase activity
IDA
PMID:20538976
Loss of human Greatwall results in G2 arrest and multiple mi...
ACCEPT
Summary: Human Greatwall (MAST-L) kinase activity assayed directly; the cached abstract-only record names the kinase and its PP2A-directed function.
Reason: Core catalytic activity of the gene; the kinase assays in the full text are consistent with the later identification of ENSA/ARPP19 as substrates and with Reactome's human reactions.
Supporting Evidence:
PMID:20538976
This kinase promotes mitotic entry and maintenance in human cells by inhibiting protein phosphatase 2A (PP2A), a phosphatase that dephosphorylates cyclin B-Cdc2 substrates. The complete depletion of Gwl by siRNA arrests human cells in G2.
PMID:38123684
This inhibition results in the full activation of mitotic kinases, including MASTL, which phosphorylates ARPP19 on Ser62 (pS62-ARPP19).
GO:0004674 protein serine/threonine kinase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Combined automated assignment from the AGC C-terminal domain, the MASTL-specific kinase domain signature and EC 2.7.11.1.
Reason: Consistent with the experimentally demonstrated activity.
Supporting Evidence:
PMID:38123684
This inhibition results in the full activation of mitotic kinases, including MASTL, which phosphorylates ARPP19 on Ser62 (pS62-ARPP19).
PMID:21164013
We report that inhibition of PP2A-B55Ξ΄ results from a small protein, known as Ξ±-endosulfine (Ensa), that is phosphorylated in mitosis by the protein kinase Greatwall (Gwl). This converts Ensa into a potent and specific inhibitor of PP2A-B55Ξ΄.
GO:0004674 protein serine/threonine kinase activity
TAS
Reactome:R-HSA-2168079
ACCEPT
Summary: Reactome reaction in which MASTL phosphorylates ARPP19 on Ser62.
Reason: Correct and specific description of the core reaction of the gene.
Supporting Evidence:
Reactome:R-HSA-2168079
MASTL (GWL i.e. Greatwall kinase) phosphorylates ARPP19 on serine residue S62 (Gharbi-Ayachi et al. 2010).
PMID:38123684
This inhibition results in the full activation of mitotic kinases, including MASTL, which phosphorylates ARPP19 on Ser62 (pS62-ARPP19).
GO:0004674 protein serine/threonine kinase activity
TAS
Reactome:R-HSA-2430535
ACCEPT
Summary: Reactome reaction in which MASTL phosphorylates ENSA on Ser67.
Reason: Correct and specific description of the core reaction of the gene.
Supporting Evidence:
Reactome:R-HSA-2430535
MASTL (GWL) activates ENSA by phosphorylating it on serine residue S67 (Mochida et al. 2010, Gharbi-Ayachi et al. 2010).
PMID:21164013
We report that inhibition of PP2A-B55Ξ΄ results from a small protein, known as Ξ±-endosulfine (Ensa), that is phosphorylated in mitosis by the protein kinase Greatwall (Gwl). This converts Ensa into a potent and specific inhibitor of PP2A-B55Ξ΄.
GO:0005524 ATP binding
IEA
GO_REF:0000002
ACCEPT
Summary: ATP binding implied by the protein kinase domain; Lys72 mutation abolishes activity and a minimal domain construct shows ATP-dependent catalysis.
Reason: Standard cofactor/substrate annotation for an active protein kinase, consistent with the UniProt ATP-binding features and the demonstrated catalytic activity.
Supporting Evidence:
file:human/MASTL/MASTL-uniprot.txt
BINDING 41..49 /ligand="ATP"
GO:0005634 nucleus
EXP
PMID:19460416
In vivo inactivation of MASTL kinase results in thrombocytop...
ACCEPT
Summary: RFP-tagged wild-type and E167D MASTL localize to the nucleus of transfected cells.
Reason: Direct imaging of the human protein; consistent with the interphase nuclear localization reported by the two 2010 human studies and with UniProt.
Supporting Evidence:
PMID:19460416
The MASTL kinase protein, both wildtype and mutant forms, appears to localize within the nucleus of these BHK cells (Figure 6, Panels A & B) as determined by co-localization with the DNA counterstain, TO-PRO-3.
GO:0005634 nucleus
IBA
GO_REF:0000033
ACCEPT
Summary: PAINT propagation of nuclear localization within the Greatwall subfamily, seeded by Drosophila gwl, zebrafish, pig and human MASTL.
Reason: Greatwall kinases are nuclear in interphase across metazoa; the human protein is among the experimental sources, and activation begins in the nucleus before nuclear envelope breakdown.
Supporting Evidence:
PMID:20818157
We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active.
PMID:19460416
The MASTL kinase protein, both wildtype and mutant forms, appears to localize within the nucleus of these BHK cells (Figure 6, Panels A & B) as determined by co-localization with the DNA counterstain, TO-PRO-3.
GO:0005634 nucleus
IDA
PMID:20538976
Loss of human Greatwall results in G2 arrest and multiple mi...
ACCEPT
Summary: Interphase nuclear localization of human Greatwall.
Reason: Consistent with all other localization evidence (PMID:20818157, PMID:19460416, UniProt).
Supporting Evidence:
PMID:20818157
We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active.
PMID:19460416
The MASTL kinase protein, both wildtype and mutant forms, appears to localize within the nucleus of these BHK cells (Figure 6, Panels A & B) as determined by co-localization with the DNA counterstain, TO-PRO-3.
GO:0005634 nucleus
IDA
PMID:20818157
MASTL is the human orthologue of Greatwall kinase that facil...
ACCEPT
Summary: MASTL is nuclear in interphase and partly centrosomal in mitosis.
Reason: Directly stated in the abstract.
Supporting Evidence:
PMID:20818157
We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active.
GO:0005634 nucleus
IEA
GO_REF:0000044
ACCEPT
Summary: UniProt subcellular-location keyword mapping (Nucleus).
Reason: Mirrors the experimental annotations.
Supporting Evidence:
PMID:20818157
We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active.
PMID:19460416
The MASTL kinase protein, both wildtype and mutant forms, appears to localize within the nucleus of these BHK cells (Figure 6, Panels A & B) as determined by co-localization with the DNA counterstain, TO-PRO-3.
GO:0005654 nucleoplasm
IDA
GO_REF:0000052
ACCEPT
Summary: Human Protein Atlas immunofluorescence places MASTL in the nucleoplasm.
Reason: Consistent with the interphase nuclear localization seen with tagged protein; the more specific sub-nuclear term is appropriate for a soluble kinase.
Supporting Evidence:
PMID:20818157
We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active.
PMID:19460416
The MASTL kinase protein, both wildtype and mutant forms, appears to localize within the nucleus of these BHK cells (Figure 6, Panels A & B) as determined by co-localization with the DNA counterstain, TO-PRO-3.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2168079
ACCEPT
Summary: Reactome places the MASTL-ARPP19 phosphorylation reaction in the nucleoplasm.
Reason: Consistent with interphase/prophase nuclear localization of MASTL; the same reaction also occurs in the cytoplasm after nuclear envelope breakdown, which Reactome does not model.
Supporting Evidence:
PMID:20818157
We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active.
PMID:19460416
The MASTL kinase protein, both wildtype and mutant forms, appears to localize within the nucleus of these BHK cells (Figure 6, Panels A & B) as determined by co-localization with the DNA counterstain, TO-PRO-3.
GO:0005654 nucleoplasm
TAS
Reactome:R-HSA-2430535
ACCEPT
Summary: Reactome places the MASTL-ENSA phosphorylation reaction in the nucleoplasm.
Reason: As for R-HSA-2168079.
Supporting Evidence:
PMID:20818157
We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active.
PMID:19460416
The MASTL kinase protein, both wildtype and mutant forms, appears to localize within the nucleus of these BHK cells (Figure 6, Panels A & B) as determined by co-localization with the DNA counterstain, TO-PRO-3.
GO:0005813 centrosome
IDA
PMID:20538976
Loss of human Greatwall results in G2 arrest and multiple mi...
ACCEPT
Summary: Mitotic centrosomal localization of human Greatwall.
Reason: The cached abstract does not describe localization, but the curator read the full text and the finding is independently reported for MASTL in mitosis (PMID:20818157) and recorded by UniProt.
Supporting Evidence:
PMID:20818157
We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active.
file:human/MASTL/MASTL-uniprot.txt
During interphase is mainly nuclear, upon nuclear envelope breakdown localizes at the cytoplasm and during mitosis at the centrosomes.
GO:0005813 centrosome
IEA
GO_REF:0000044
ACCEPT
Summary: UniProt subcellular-location keyword mapping (Centrosome).
Reason: Mirrors the experimental annotation.
Supporting Evidence:
PMID:20818157
We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active.
file:human/MASTL/MASTL-uniprot.txt
During interphase is mainly nuclear, upon nuclear envelope breakdown localizes at the cytoplasm and during mitosis at the centrosomes.
GO:0006974 DNA damage response
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: Transferred from Xenopus Greatwall, which is inhibited by the DNA damage response and promotes checkpoint recovery (re-entry into mitosis after damage removal) in egg extracts.
Reason: The Xenopus evidence is sound and the biology is plausible for human MASTL, but the role is an application of its core G2/M-promoting activity to the recovery phase of the checkpoint rather than a distinct DNA-damage function, and there is no direct human experimental annotation. Keep as a non-core, orthology-inferred process.
Supporting Evidence:
file:human/MASTL/MASTL-uniprot.txt
Following DNA damage, it is also involved in checkpoint recovery by being inhibited.
GO:0007346 regulation of mitotic cell cycle
IBA
GO_REF:0000033
ACCEPT
Summary: PAINT propagation across the Greatwall/Rim15/Ppk18 subfamily; all characterized members regulate the mitotic cell cycle through the endosulfine-PP2A-B55 axis.
Reason: The node placement is sound and the human protein has direct IMP evidence for the more specific G2/M transition term; this parent term correctly summarizes the conserved function.
Supporting Evidence:
PMID:20538976
This kinase promotes mitotic entry and maintenance in human cells by inhibiting protein phosphatase 2A (PP2A), a phosphatase that dephosphorylates cyclin B-Cdc2 substrates. The complete depletion of Gwl by siRNA arrests human cells in G2.
PMID:20538976
These phenotypes appear to be mediated by PP2A, as they could be rescued by either a double Gwl/PP2A knockdown or by the inhibition of this phosphatase with okadaic acid.
PMID:21164014
We identified cyclic adenosine monophosphate-regulated phosphoprotein 19 (Arpp19) and Ξ±-Endosulfine as two substrates of Gwl that, when phosphorylated by this kinase, associate with and inhibit PP2A, thus promoting mitotic entry.
GO:0007346 regulation of mitotic cell cycle
TAS
Reactome:R-HSA-2465910
ACCEPT
Summary: Reactome pathway 'MASTL Facilitates Mitotic Progression'.
Reason: Accurate summary of the core function.
Supporting Evidence:
Reactome:R-HSA-2465910
Activated MASTL phosphorylates ARPP19 and ENSA on serines S62 and S67, respectively, enabling them to bind to and inhibit the phosphatase activity of PP2A complexed with the regulatory subunit PPP2R2D (B55-delta).
GO:0015630 microtubule cytoskeleton
IBA
GO_REF:0000033
ACCEPT
Summary: PAINT propagation of microtubule-cytoskeleton localization, reflecting the mitotic centrosomal localization of vertebrate Greatwall.
Reason: MASTL localizes to centrosomes in mitosis (a part of the microtubule cytoskeleton) and the human protein is among the experimental sources; the term is the appropriate generalization for the subfamily node.
Supporting Evidence:
PMID:20818157
We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active.
file:human/MASTL/MASTL-uniprot.txt
During interphase is mainly nuclear, upon nuclear envelope breakdown localizes at the cytoplasm and during mitosis at the centrosomes.
GO:0016301 kinase activity
IDA
PMID:20818157
MASTL is the human orthologue of Greatwall kinase that facil...
MODIFY
Summary: Kinase activity of MASTL is demonstrated, but the generic term is less informative than the established protein serine/threonine kinase activity.
Reason: The activity is real; the cited study shows active MASTL in mitosis, and its substrates ENSA Ser67 and ARPP19 Ser62 are serine residues in proteins. Use the specific protein serine/threonine kinase term already carried by the gene.
Supporting Evidence:
PMID:20818157
We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active.
PMID:38123684
This inhibition results in the full activation of mitotic kinases, including MASTL, which phosphorylates ARPP19 on Ser62 (pS62-ARPP19).
GO:0032154 cleavage furrow
IDA
PMID:20538976
Loss of human Greatwall results in G2 arrest and multiple mi...
ACCEPT
Summary: Human Greatwall localizes to the cleavage furrow at mitotic exit.
Reason: The cached abstract is silent on this, but the same localization is recorded by UniProt from PMID:20818157 and is consistent with the cytokinesis defects seen after depletion.
Supporting Evidence:
file:human/MASTL/MASTL-uniprot.txt
Upon mitotic exit moves to the cleavage furrow.
PMID:20818157
MASTL RNAi cells that enter and progress through mitosis often fail to completely separate their sister chromatids in anaphase. This causes chromatin to be trapped in the cleavage furrow, which may lead to the formation of 4N G(1) cells by cytokinesis failure.
GO:0032154 cleavage furrow
IDA
PMID:20818157
MASTL is the human orthologue of Greatwall kinase that facil...
ACCEPT
Summary: MASTL relocalizes to the cleavage furrow at mitotic exit.
Reason: Source of the UniProt subcellular-location statement; consistent with the cytokinesis phenotype of depleted cells.
Supporting Evidence:
file:human/MASTL/MASTL-uniprot.txt
Upon mitotic exit moves to the cleavage furrow.
PMID:20818157
MASTL RNAi cells that enter and progress through mitosis often fail to completely separate their sister chromatids in anaphase. This causes chromatin to be trapped in the cleavage furrow, which may lead to the formation of 4N G(1) cells by cytokinesis failure.
GO:0032154 cleavage furrow
IEA
GO_REF:0000044
ACCEPT
Summary: UniProt subcellular-location keyword mapping (Cleavage furrow).
Reason: Mirrors the experimental annotation.
Supporting Evidence:
file:human/MASTL/MASTL-uniprot.txt
Upon mitotic exit moves to the cleavage furrow.
PMID:20818157
MASTL RNAi cells that enter and progress through mitosis often fail to completely separate their sister chromatids in anaphase. This causes chromatin to be trapped in the cleavage furrow, which may lead to the formation of 4N G(1) cells by cytokinesis failure.
GO:0035556 intracellular signal transduction
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: PAINT propagation of a generic signalling term from the deep AGC-kinase node (PTN000683254), the same node as the serine/threonine kinase IBA.
Reason: MASTL does relay a signal inside the cell (cyclin B-CDK1 activates MASTL, which phosphorylates ENSA/ARPP19 to switch off PP2A-B55), so the term is not wrong and the node placement is defensible for the AGC family. It adds nothing beyond the mitotic cell-cycle terms, so it is retained as a non-core, generic parent rather than as a core function.
Supporting Evidence:
PMID:20538976
This kinase promotes mitotic entry and maintenance in human cells by inhibiting protein phosphatase 2A (PP2A), a phosphatase that dephosphorylates cyclin B-Cdc2 substrates. The complete depletion of Gwl by siRNA arrests human cells in G2.
PMID:20538976
These phenotypes appear to be mediated by PP2A, as they could be rescued by either a double Gwl/PP2A knockdown or by the inhibition of this phosphatase with okadaic acid.
PMID:21164014
We identified cyclic adenosine monophosphate-regulated phosphoprotein 19 (Arpp19) and Ξ±-Endosulfine as two substrates of Gwl that, when phosphorylated by this kinase, associate with and inhibit PP2A, thus promoting mitotic entry.
GO:0044325 transmembrane transporter binding
IEA
GO_REF:0000107
REMOVE
Summary: Ensembl Compara projection of a mouse Mastl IPI (binding to the K-Cl cotransporter Slc12a6/KCC3) whose source publication has been retracted.
Reason: The only support is an electronic transfer of a mouse interaction annotation (PMID:27782176, a kinome screen for cation-chloride cotransporter regulators) that PubMed now lists as a retracted article. There is no human evidence that MASTL binds any transmembrane transporter, and the claim has no connection to the established endosulfine-PP2A biology. Removal does not assert that the mouse interaction was false, only that it is unsupported and uninformative for the human gene.
GO:0051721 protein phosphatase 2A binding
ISS
GO_REF:0000024
MARK AS OVER ANNOTATED
Summary: Transferred from Xenopus Greatwall, which co-precipitates PP2A from egg extracts; the subsequent substrate work showed that Greatwall inhibits PP2A-B55 indirectly through phospho-ENSA/ARPP19 rather than by binding the phosphatase itself.
Reason: A Gwl-PP2A association was reported in Xenopus extracts before the endosulfine mechanism was known, and it is most simply explained by the ternary Gwl-phospho-endosulfine-PP2A-B55 context. UniProt itself states that MASTL 'does not directly inhibit PP2A'. For human MASTL no direct binding has been demonstrated, and presenting PP2A binding as a molecular function of the kinase misrepresents the mechanism; the informative molecular function is the serine kinase activity toward ENSA/ARPP19.
Supporting Evidence:
file:human/MASTL/MASTL-uniprot.txt
does not directly inhibit PP2A but acts by mediating phosphorylation and subsequent activation of ARPP19 and ENSA
PMID:21164014
We identified cyclic adenosine monophosphate-regulated phosphoprotein 19 (Arpp19) and Ξ±-Endosulfine as two substrates of Gwl that, when phosphorylated by this kinase, associate with and inhibit PP2A, thus promoting mitotic entry.
GO:0051726 regulation of cell cycle
IMP
PMID:20818157
MASTL is the human orthologue of Greatwall kinase that facil...
MODIFY
Summary: MASTL depletion causes G2 delay, incomplete anaphase and cytokinesis failure; the phenotype is specifically a mitotic cell-cycle defect.
Reason: The evidence is sound but the term is broader than necessary. All the reported phenotypes (G2 delay, slow chromosome condensation, anaphase and cytokinesis failure, incomplete cyclin B1 destruction) concern the mitotic cell cycle, so the more specific regulation of mitotic cell cycle term (already carried by IBA and Reactome) should be used; the same paper also supports the G2/M transition annotation.
Proposed replacements: regulation of mitotic cell cycle
Supporting Evidence:
PMID:20818157
Cells strongly depleted of MASTL by RNAi delay in G(2) phase and reveal slow chromosome condensation.
PMID:20818157
MASTL RNAi cells that enter and progress through mitosis often fail to completely separate their sister chromatids in anaphase. This causes chromatin to be trapped in the cleavage furrow, which may lead to the formation of 4N G(1) cells by cytokinesis failure.
GO:0106310 protein serine kinase activity
IEA
GO_REF:0000116
ACCEPT
Summary: Rhea-derived protein serine kinase activity; the physiological sites ENSA Ser67 and ARPP19 Ser62 are serines.
Reason: Correct and, for the known substrates, the most precise catalytic term.
Supporting Evidence:
PMID:38123684
This inhibition results in the full activation of mitotic kinases, including MASTL, which phosphorylates ARPP19 on Ser62 (pS62-ARPP19).
PMID:21164013
We report that inhibition of PP2A-B55Ξ΄ results from a small protein, known as Ξ±-endosulfine (Ensa), that is phosphorylated in mitosis by the protein kinase Greatwall (Gwl). This converts Ensa into a potent and specific inhibitor of PP2A-B55Ξ΄.
GO:0005737 cytoplasm
IDA
PMID:20818157
MASTL is the human orthologue of Greatwall kinase that facil...
NEW
Summary: Proposed cellular-component annotation. After nuclear envelope breakdown MASTL is dispersed through the mitotic cytoplasm, where it phosphorylates ENSA/ARPP19 to keep PP2A-B55 inhibited; the existing nucleus/centrosome/cleavage-furrow terms do not capture this compartment.
Reason: UniProt records the cytoplasmic localization upon nuclear envelope breakdown from PMID:20818157, and the mitotic phosphorylation of the endosulfines and inhibition of PP2A-B55 necessarily take place in the cytoplasm once the nuclear envelope has broken down. This is a localization statement supported by curated data, not a new process claim.
Supporting Evidence:
file:human/MASTL/MASTL-uniprot.txt
During interphase is mainly nuclear, upon nuclear envelope breakdown localizes at the cytoplasm and during mitosis at the centrosomes.
file:human/MASTL/MASTL-deep-research-falcon.md
The protein is predominantly nuclear in interphase and becomes dispersed after nuclear-envelope breakdown.
PMID:20818157
We found that MASTL localizes to the nucleus in interphase and re-localizes in part to centrosomes in mitosis, when it is active.

Core Functions

Cyclin B-CDK1-activated protein serine kinase that phosphorylates the endosulfines ENSA (Ser67) and ARPP19 (Ser62), converting them into inhibitors of PP2A-B55 so that CDK1 substrate phosphorylation can accumulate and the cell commits to mitosis at the G2/M transition.

Supporting Evidence:
  • PMID:20538976
    This kinase promotes mitotic entry and maintenance in human cells by inhibiting protein phosphatase 2A (PP2A), a phosphatase that dephosphorylates cyclin B-Cdc2 substrates. The complete depletion of Gwl by siRNA arrests human cells in G2.
  • PMID:21164014
    We identified cyclic adenosine monophosphate-regulated phosphoprotein 19 (Arpp19) and Ξ±-Endosulfine as two substrates of Gwl that, when phosphorylated by this kinase, associate with and inhibit PP2A, thus promoting mitotic entry.
  • PMID:21164013
    We report that inhibition of PP2A-B55Ξ΄ results from a small protein, known as Ξ±-endosulfine (Ensa), that is phosphorylated in mitosis by the protein kinase Greatwall (Gwl). This converts Ensa into a potent and specific inhibitor of PP2A-B55Ξ΄.
  • PMID:38123684
    This inhibition results in the full activation of mitotic kinases, including MASTL, which phosphorylates ARPP19 on Ser62 (pS62-ARPP19).

Sustains the mitotic phosphorylation state through prometaphase, anaphase and cytokinesis by keeping PP2A-B55 inhibited via phospho-ENSA/ARPP19, so that the spindle assembly checkpoint, chromatid separation and cytokinesis complete correctly; its inactivation at mitotic exit allows PP2A-B55 reactivation and an orderly return to interphase.

Supporting Evidence:
  • PMID:20538976
    These phenotypes appear to be mediated by PP2A, as they could be rescued by either a double Gwl/PP2A knockdown or by the inhibition of this phosphatase with okadaic acid.
  • PMID:20818157
    our experiments indicate that MASTL supports the phosphorylation state of mitotic phospho-proteins downstream of cyclin B1-Cdk1, including the APC/C.
  • PMID:20818157
    MASTL RNAi cells that enter and progress through mitosis often fail to completely separate their sister chromatids in anaphase. This causes chromatin to be trapped in the cleavage furrow, which may lead to the formation of 4N G(1) cells by cytokinesis failure.
  • Reactome:R-HSA-2465910
    Inhibition of PP2A-PPP2R2D activity by ARPP19 or ENSA prevents dephosphorylation of CDK1 targets, hence allowing entry and maintenance of mitosis (Mochida et al. 2010, Gharbi-Ayachi et al. 2010, Burgess et al. 2010).

References

Loading supporting content…

Download this section (compressed HTML)

Suggested Questions for Experts

Q: Does human MASTL physically bind PP2A-B55 independently of phospho-ENSA/ARPP19, as the Xenopus co-precipitation data suggested, or is the association entirely bridged by the phospho-endosulfines? This determines whether 'protein phosphatase 2A binding' should be retained for the human protein.

Suggested experts: Anna Castro, Thierry Lorca

Q: Does the THC2-associated E167D variant alter kinase output toward ENSA/ARPP19 in megakaryocytes (a gain or loss of PP2A-B55 suppression), or does the platelet phenotype arise from a kinase-independent activity?

Suggested experts: Jonathan G. Drachman

Suggested Experiments

Experiment: Acute degron-mediated (dTAG/AID) depletion of endogenous MASTL in mitotically arrested human cells, combined with PP2A-B55 inhibition or ENSA/ARPP19 phosphomimetic rescue, followed by quantitative phosphoproteomics to separate direct MASTL sites from PP2A-B55-dependent losses.

Hypothesis: ENSA and ARPP19 are the only physiological mitotic substrates of MASTL; other reported phosphorylation changes after MASTL loss are secondary to PP2A-B55 reactivation.

Type: phosphoproteomics / degron genetics

Experiment: CRISPR knock-in of MASTL E167D in human iPSC-derived megakaryocytes; measure pENSA Ser67 and pARPP19 Ser62, polyploidization and proplatelet output relative to isogenic controls and to a kinase-dead allele.

Hypothesis: The E167D variant changes the balance of endosulfine phosphorylation in megakaryocytes and thereby alters proplatelet formation.

Type: genome editing / cell biology

Deep Research

Falcon

(MASTL-deep-research-falcon.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(MASTL-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)